- Home
- TIL vs EDF Comparison
TIL vs EDF Comparison
Compare TIL & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- EDF
- Stock Information
- Founded
- TIL 2018
- EDF 2010
- Country
- TIL United States
- EDF United States
- Employees
- TIL N/A
- EDF N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- EDF Investment Managers
- Sector
- TIL Health Care
- EDF Finance
- Exchange
- TIL Nasdaq
- EDF Nasdaq
- Market Cap
- TIL 171.7M
- EDF 148.8M
- IPO Year
- TIL 2021
- EDF N/A
- Fundamental
- Price
- TIL $14.48
- EDF $4.89
- Analyst Decision
- TIL Buy
- EDF
- Analyst Count
- TIL 5
- EDF 0
- Target Price
- TIL $114.00
- EDF N/A
- AVG Volume (30 Days)
- TIL 178.2K
- EDF 160.6K
- Earning Date
- TIL 05-13-2025
- EDF 01-01-0001
- Dividend Yield
- TIL N/A
- EDF 13.14%
- EPS Growth
- TIL N/A
- EDF N/A
- EPS
- TIL N/A
- EDF N/A
- Revenue
- TIL N/A
- EDF N/A
- Revenue This Year
- TIL N/A
- EDF N/A
- Revenue Next Year
- TIL N/A
- EDF N/A
- P/E Ratio
- TIL N/A
- EDF N/A
- Revenue Growth
- TIL N/A
- EDF N/A
- 52 Week Low
- TIL $9.62
- EDF $3.51
- 52 Week High
- TIL $92.00
- EDF $5.50
- Technical
- Relative Strength Index (RSI)
- TIL 46.45
- EDF 52.76
- Support Level
- TIL $10.80
- EDF $4.88
- Resistance Level
- TIL $13.52
- EDF $5.03
- Average True Range (ATR)
- TIL 2.23
- EDF 0.10
- MACD
- TIL -0.17
- EDF 0.05
- Stochastic Oscillator
- TIL 27.06
- EDF 78.68
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.